Abstract
In the mouse, cross-presentation is an exclusive property of the CD8alpha+ subset of dendritic cells (DC) but the basis for this selectivity remains unclear. Here we report that splenic CD8alpha+ DC are much superior to other DC subsets in internalizing dying cells in vitro. In contrast, CD8alpha+, CD8alpha- CD4+ and CD8alpha- CD4- DC subsets phagocytose bacteria or latex beads to a similar extent. Although CD8alpha+ DC are better than CD4+ DC at presenting ovalbumin (OVA)-loaded splenocytes to naïve OT-I T lymphocytes, CD4+ DC are better at presenting OVA-expressing Escherichia coli to the same T cells. In both cases, presentation is abrogated by lactacystin. These results show that both splenic CD8alpha+ and CD8alpha- DC can present exogenous antigens on major histocompatibility complex (MHC) class I via a proteasome-dependent pathway and suggest that the specialized cross-presenting function of CD8alpha+ DC is a result of their ability to endocytose dying cells rather than a unique pathway for handling endosomal contents.
MeSH Terms
Animals
Antigen Presentation/immunology
Antigens, Bacterial/immunology
Apoptosis/immunology
CD4 Antigens/analysis
CD8 Antigens/analysis
Cell Culture Techniques
Dendritic Cells/immunology
Escherichia coli/immunology
Female
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Microscopy, Video
Ovalbumin/immunology
Phagocytosis/immunology
Chemicals
Antigens, Bacterial
CD4 Antigens
CD8 Antigens
CD8alpha antigen
Ovalbumin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Schulz Oliver
Immunobiology Laboratory, Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.
Reis e Sousa Caetano
References (28)
28 references, click to expand
-
Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
Nat Cell Biol. 1999 Oct;1(6):362-8
PMID: 10559964
-
CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells.
J Immunol. 2002 Jun 15;168(12):6057-65
PMID: 12055214
-
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.
J Exp Med. 2000 Dec 18;192(12):1685-96
PMID: 11120766
-
The development, maturation, and turnover rate of mouse spleen dendritic cell populations.
J Immunol. 2000 Dec 15;165(12):6762-70
PMID: 11120796
-
From evil to good: a cytolysin in vaccine development.
Trends Microbiol. 2001 Jan;9(1):23-8
PMID: 11166239
-
Dendritic cells acquire antigens from live cells for cross-presentation to CTL.
J Immunol. 2001 Mar 15;166(6):3717-23
PMID: 11238612
-
Cross-presentation, dendritic cells, tolerance and immunity.
Annu Rev Immunol. 2001;19:47-64
PMID: 11244030
-
Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
J Immunol. 2001 May 1;166(9):5327-30
PMID: 11313367
-
Antigen presentation to CD8+ T cells: cross-priming in infectious diseases.
Curr Opin Immunol. 2001 Aug;13(4):437-41
PMID: 11498299
-
Antigen presentation and T cell stimulation by dendritic cells.
Annu Rev Immunol. 2002;20:621-67
PMID: 11861614
-
Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8alpha+ dendritic cells in vivo.
J Exp Med. 2002 Mar 18;195(6):683-94
PMID: 11901195
-
Mouse and human dendritic cell subtypes.
Nat Rev Immunol. 2002 Mar;2(3):151-61
PMID: 11913066
-
The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo.
J Exp Med. 2002 May 20;195(10):1289-302
PMID: 12021309
-
CD36 is differentially expressed by CD8+ splenic dendritic cells but is not required for cross-presentation in vivo.
J Immunol. 2002 Jun 15;168(12):6066-70
PMID: 12055215
-
Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter.
J Immunol. 2002 Jul 1;169(1):108-16
PMID: 12077235
-
Antigen recognition. Class discrimination in the world of immunology.
Nature. 1987 Jan 15-21;325(6101):192-4
PMID: 2433584
-
Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.
Nature. 1993 Jan 28;361(6410):359-62
PMID: 7678924
-
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4942-6
PMID: 8506338
-
T cell receptor antagonist peptides induce positive selection.
Cell. 1994 Jan 14;76(1):17-27
PMID: 8287475
-
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.
Cell. 1994 Sep 9;78(5):761-71
PMID: 8087844
-
Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
J Immunol. 1994 Dec 1;153(11):4925-33
PMID: 7963555
-
A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules.
Science. 1995 Jan 13;267(5195):243-6
PMID: 7809629
-
Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.
J Exp Med. 1995 Sep 1;182(3):841-51
PMID: 7650490
-
Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes.
Eur J Immunol. 1996 Nov;26(11):2595-600
PMID: 8921944
-
Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells.
Eur J Immunol. 1997 Jan;27(1):280-8
PMID: 9022030
-
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.
J Exp Med. 1999 Jan 18;189(2):371-80
PMID: 9892619
-
Delivery of protein to the cytosol of macrophages using Escherichia coli K-12.
Mol Microbiol. 1999 Mar;31(6):1631-41
PMID: 10209738
-
CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen.
J Immunol. 2000 Mar 15;164(6):2978-86
PMID: 10706685